Go Back
Gilead Sciences
Gilead Sciences, a Corporate VC based in Foster City, was founded in 1987. The fund focuses on Series B, Series C, and Series D stages in sectors like BioTech, Life Science, Healthcare, and Pharmaceuticals. Partnered with Alesha Petrov, they have invested in companies like Kyverna Therapeutics and Tizona Therapeutics. With 29 investments and 10 exits, Gilead Sciences is dedicated to discovering and commercializing therapies for critical diseases in the medical field. For more information, visit their website at www.gilead.com.
About
About
About
Bio
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Location
Foster City
Stage
Series C, Series D, Series B
Partner name
Alesha Petrov
Bio
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Location
Foster City
Stage
Series C, Series D, Series B
Partner name
Alesha Petrov
Fund
Fund
Fund
Fund Focus
BioTech, Life Science, Healthcare, Medical Device, Pharmaceuticals, CloudTech, Enterprise, Software, Manufacturing
Number of investments
29
Number of exits
10
Fund Type
Corporate VC
Portfolio Companies
Kyverna Therapeutics, Goldfinch Biopharma, Pionyr Immunotherapeutics, Vineti, Tizona Therapeutics, Lyndra Therapeutics, Tmunity Therapeutics
Gilead Sciences
Gilead Sciences, a Corporate VC based in Foster City, was founded in 1987. The fund focuses on Series B, Series C, and Series D stages in sectors like BioTech, Life Science, Healthcare, and Pharmaceuticals. Partnered with Alesha Petrov, they have invested in companies like Kyverna Therapeutics and Tizona Therapeutics. With 29 investments and 10 exits, Gilead Sciences is dedicated to discovering and commercializing therapies for critical diseases in the medical field. For more information, visit their website at www.gilead.com.
About
Bio
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Location
Foster City
Stage
Series C, Series D, Series B
Partner name
Alesha Petrov
Fund
Fund Focus
BioTech, Life Science, Healthcare, Medical Device, Pharmaceuticals, CloudTech, Enterprise, Software, Manufacturing
Number of investments
29
Number of exits
10
Fund Type
Corporate VC
Portfolio Companies
Kyverna Therapeutics, Goldfinch Biopharma, Pionyr Immunotherapeutics, Vineti, Tizona Therapeutics, Lyndra Therapeutics, Tmunity Therapeutics